Clinical Trial Update: Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel and cisplatin with or without a high-dose proton pump inhibitor in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer, Metastasis, Neoplasm | Phase 2 | Status: COMPLETED